Financial Advisor

Theriva Biologics (TOVX) secured $4.0 million (potentially $4.4 million total) by incentivizing warrant exercises at $0.54. Investors receive new warrants for twice the shares exercised (up to 14,720,920 shares), exercisable post-stockholder approval and expiring in five years. Proceeds fund working capital. The deal provides immediate liquidity while shifting dilution risk to the future, contingent on shareholder approval and SEC registration for the new warrants. A.G.P./Alliance Global Partners advised on the transaction.

UBS Wealth Management US welcomes Mellany Bagtas as a Financial Advisor in New York City, based at the 299 Park Avenue office. Bagtas, previously at Morgan Stanley, brings experience to serve high-net-worth clients, offering tailored financial strategies. UBS highlights her expertise in wealth preservation, planning, and customized solutions.